Dr Anthony Zulli
Senior Lecturer, College of Health & Biomedicine
Dr Zulli joined Victoria University after finishing his NHMRC Peter Doherty Fellowship in 2009 (2006-2009, University of Melbourne, Austin Health).
His research focuses on the mechanisms that cardiovascular disease risk factors (homocysteine/cholesterol) cause endothelial dysfunction. His research has an emphasis on the nitric oxide pathway and renin-angiotensin system, and has a recent focus on endothelial derived microparticles. Dr Zulli has been funded by the National Heart Foundation and NHMRC, as well as internal VU grant schemes.
He has published over 50 manuscripts, attracted over $1 million in funds and collaborates with both national and international scientists.
Recent selected publications
Kruzliak, P., Hare, D.L., Zvonicek, V., Klimas, J., Zulli, A. (2015). Simvastatin impairs the induction of pulmonary fibrosis caused by a western style diet: A preliminary study. J Cell Mol Med. 19(11):2647-54.
Alsaadon, H., Kruzliak, P., Smardencas, A., Hayes, A., Bader, M., Angus, P., Herath, C., Zulli, A. (2015). Increased aortic intimal proliferation due to MasR deletion in vitro. Int J Exp Pathol. 96(3):183-7.
Berezin, A., Zulli, A., Kerrigan, S., Petrovic, D., Kruzliak, P. (2015). Predictive role of circulating endothelial-derived microparticles in cardiovascular diseases. Clin Biochem. 48(9):562-8.
Smith, R.M., Kruzliak, P., Adamcikova, Z., Zulli, A. (2015). Role of Nox inhibitors plumbagin, ML090 and gp91ds-tat peptide on homocysteine thiolactone induced blood vessel dysfunction. Clin Exp Pharmacol Physiol. 42(8):860-4.
Habiyakare, B., Alsaadon, H., Mathai, M.L., Hayes, A., Zulli, A. (2014). Reduction of angiotensin A and alamandine vasoactivity in the rabbit model of atherogenesis: differential effects of alamandine and Ang(1-7). Int J Exp Pathol. 95(4):290-5.
Wookey, P.J., Zulli, A., Lo, C., Hare, D.L., Schwarer, A.P., Darby, I.A., Leung, A.Y. (2008). Calcitonin receptor (CTR) expression in embryonic, foetal and adult tissues: developmental and pathophysiological implications. In The calcitonin gene-related family: form, function and future perspectives, Eds Drs. Debbie L Hay and Ian M Dickerson. Springer.
Coordinator for first year Bioscience (HBNB) and third year Pharmacology (SBBS).
Postgraduate research students and fellows
- Advanced Medical Science, University of Melbourne, 23 students
- Honours, University of Melbourne and Victoria University, 15 students.
- Five honours students
- Three PhD students.
- 2012: Victoria University Research Development Grant Scheme, $30,000
- 2007-8: National Heart Foundation, $126,000. CIA – A Zulli
- 2006: University of Melbourne Seeding Grant, $18,000. CIA – A. Zulli
- 2005-6 National Heart Foundation, $120,000. CID – A. Zulli
- 2003-7 Austin Hospital Medical Research Foundation, 2003 - $10,000; 2004 - $7,500; 2005 - $14,300; 2006a - $7,500; 2006b - $7,500; 2007 – $13,000
- Australian Atherosclerosis Society
- Australian Vascular Biology Society
- High Blood Pressure Research Council
Appearances in the media
3RRR, Radiotherapy: Homocysteine and coronary artery disease, 4 July, 2004
3RRR, Radiotherapy: Taurine and coronary artery disease, 1 March, 2009
Areas of expertise
- Examining the effect of homocysteine on activating the Mas receptor
- Examining the effect of treatments on coronary artery disease in a rabbit model
- Examining the role of the Mas receptor in endothelial dysfunction